大动脉置换与气球可扩展和自我扩展的跨导管植入低风险患者
Vittoria Lodo1, Enrico Giuseppe Italiano2, Luca Weltert3
1Department of Cardiac Surgery, Mauriziano Hospital, 10128 Turin, Italy.
Journal of clinical medicine
|December 11, 2025
概括
对于低风险患者,气球可扩展 (BE) 跨导管大动脉植入 (TAVI) 显示与手术大动脉置换 (SAVR) 不逊色. 与SAVR相比,自扩展 (SE) TAVI与较高的中风和死亡风险有关.
科学领域:
- 心脏病学 心脏病学
- 干预心脏病学 干预心脏病学
- 心脏外科手术 心脏外科手术
背景情况:
- 过导管大动脉植入 (TAVI) 为外科大动脉置换 (SAVR) 提供了一个替代方案.
- 将不同类型的TAVI假肢 (气球可扩展与自扩展) 的中期结果与SAVR进行比较对于患者选择至关重要.
研究的目的:
- 为了比较接受SAVR的低风险患者的中期结果与气球可扩展 (BE) 或自扩展 (SE) TAVI.
- 为了评估假肢类型对中风,准膜泄漏,左捆支部阻塞和长期死亡率的影响.
主要方法:
- 对542名接受SAVR或输血性TAVI (2017-2022) 的患者进行了回顾性分析.
- 患者被分为SAVR,BE-TAVI和SE-TAVI组.
- 倾向性得分匹配用于创建可比的队列进行分析.
主要成果:
- 在匹配的队列中,与BE-TAVI和SAVR相比,SE-TAVI显示出较高的中风,准膜泄漏和左捆分支阻塞率.
- 在BE-TAVI和SE-TAVI之间没有显著的5年死亡率差异.
- 与SAVR相比,SE-TAVI显示出明显更高的5年死亡率,而BE-TAVI不低于SAVR.
结论:
- 气球可扩展的TAVI是SAVR的合适替代品,适用于具有长寿命的低风险患者.
- 与SAVR相比,自扩展型TAVI在这个人群中与风险和死亡率的增加有关.
- 对于符合条件的患者来说,BE假肢应该被认为是首选的跨导管选择.
更多相关视频
05:31Transcatheter Pulmonary Valve Replacement from Autologous Pericardium with a Self-Expandable Nitinol Stent in an Adult Sheep Model
Published on: June 8, 2022
3.3K
06:04Upper-extremity Approach for Secondary Access in Transfemoral Transcatheter Aortic Valve Implantation
Published on: August 8, 2025
474
相关概念视频
Mitral Valve Prolapse II: Assessment and Management
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular tachycardia.
Mitral Stenosis III: Medical Management
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Aortic Regurgitation III: Medical Management
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
